Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poly ICLC, Cyclophosphamide, Radiotherapy, and Embolization in Liver Cancers
NCT00553683Phase 2Unknown
- Sponsor
- Rutgers University
- Start
- Oct 2007
- Primary completion
- Feb 2014
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of poly iclc in liver cancer, sponsored by Rutgers University. Status: unknown.
02
Drugs
poly iclc
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT00553683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553683.